Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2393-2408

  Bathen, Tone Frost ^a,d   Engan, Terje ^b   Krane, Jostein ^a   Axelson, David ^c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c QUEEN S UNIVERSITY   (Canada)

^d SINTEF   (Norway)

Author keywords

1H NMR; Cancer; CHD; Cholesterol; GTM; HDL; LDL; Lipoprotein; PNN; SOM; Triglyceride; VLDL

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRACENTRIFUGATION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; HUMANS; KIDNEY FAILURE; LIPIDS; LIPOPROTEINS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASMS; NEURAL NETWORKS (COMPUTER); TAMOXIFEN;

EID: 0033863403     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Engan T, Bjerve KS, Hoe AL and Krane J:Characterization of plasma lipids in patients with malignant disease by 13C nuclear magnetic resonance spectroscopy and gas liquid chromatography. Blood 85: 1323-1330, 1995.
2. Engan T, Bjerve TK, Hoe AL and Krane J: Proton magnetic resonance spectroscopy of fractionated plasma lipoproteins and reconstituted plasma from healthy subjects and patients with cancer. Scand J: Lab Invest 52: 393-408, 1992.
3. Engan T, Krane J, Klepp O and Kvinnsland S: Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer. New Engl J Med 322: 949-953, 1990.
4. Engan T, Krane J and Kvinnsland S: Proton nuclear magnetic resonance spectroscopy measurements of methylene and methyl line widths in plasma: Significant variations with extent of breast cancer, duration of pregnancy and age. NMR Biomed 4: 142-149, 1991.
5. Yamada K, Araki S, Tamura M, Sakai I, Takahashi Y, Kashihara H and Kono S: Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int J Epidemiol 27: 794-798, 1998.
6. Baro L, Hermoso J-L, Nunez M-C, Jimenez-Rios J-A and Gil A: Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer. Br J Cancer 77: 1978-1983, 1998.
7. Halton JM, Nazir DJ, McQueen MJ and Barr RD: Blood lipid profiles in children with acute lymphoblastic leukemia. Cancer 83: 379-384, 1998.
8. Parsons SK, Skapek SX, Neufeld EJ, Kuhlman C, Young ML, Donnelly M, Brunzell JD, Otvos JD, Sallan SJ and Rifai N: Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood 59: 1886-1895, 1997.
9. Ala-Korpela M, Hiltunen Y and Bell JD: Quantification of biomedical NMR data using artificial neural network analysis: Lipoprotein lipid profiles from 1H NMR data of human plasma. NMR Biomed 8: 235-244, 1995.
10. Hiltunen Y, Heiniemi E and Ala-Korpcla M Lipoprotein-lipid quantification by neural-network analysis of 1H NMR data from human blood plasma. J.Magn Reson B 106: 191-194, 1995.
11. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ: and Walker JA Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vase Biol 18: 1046-1053, 1998.
12. Otvos JD: Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. In: Rifai N, Warnick G, Dominiczak MH, eds. Handbook of lipoprotein testing. Washington, DC: AACC Press, 1997: 497-508.
13. Otvos JD, Jeyarajah EJ and Bennett DW: Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 37: 377-386, 1991.
14. Otvos JD, Jeyarajah EJ, Bennett DW and Krauss RM: Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 38: 1632-1638, 1992.
15. Ala-Korpela M, Hiltunen Y, Jokisaari J, Eskelinen S, Kiviniitty K, Savolainen MJ and Kesaniemi YA: A comparative study of 1H NMR lineshape fitting anlyses and biochemical lipid analyses of the lipoprotein fractions VLDL, LDL and HDL, and total human blood plasma. NMR Biomed 6: 225-233, 1993.
16. Ala-Korpela M, Korhonen A, Keisala J, Horkko S, Korpi P, Ingman LP, Jokisaari J, Savolainen MJ and Kesaniemi YA: 1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma. J Lipid Res 35: 2292-2304, 1994.
17. Serrai H, Nadal L, Leray G, Leroy B, Delplanque B and de Certaines JD: Quantificarion of plasma lipoprotein fractions by wavelet transform time-domain data processing of the proton nuclear magnetic resonance methylene spectral region. NMR Biomed 11: 273-280, 1998.